JP2020529433A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529433A5 JP2020529433A5 JP2020505835A JP2020505835A JP2020529433A5 JP 2020529433 A5 JP2020529433 A5 JP 2020529433A5 JP 2020505835 A JP2020505835 A JP 2020505835A JP 2020505835 A JP2020505835 A JP 2020505835A JP 2020529433 A5 JP2020529433 A5 JP 2020529433A5
- Authority
- JP
- Japan
- Prior art keywords
- isopropyl
- indole
- piperidine
- methyl
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 -C (O) NR x R x Chemical group 0.000 claims 180
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical group C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 claims 34
- 125000000217 alkyl group Chemical group 0.000 claims 24
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims 20
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 14
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 13
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 12
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 12
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 229910052799 carbon Inorganic materials 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 9
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 6
- 125000003386 piperidinyl group Chemical group 0.000 claims 6
- 125000003226 pyrazolyl group Chemical group 0.000 claims 6
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 4
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims 4
- RJSNRCXIBJVKJX-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCC(CC1)C(F)(F)F)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCC(CC1)C(F)(F)F)C1=CN(C)C(=O)C(C)=C1 RJSNRCXIBJVKJX-UHFFFAOYSA-N 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 4
- 125000002757 morpholinyl group Chemical group 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 4
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 3
- SBBGZULIWVSWTC-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 SBBGZULIWVSWTC-UHFFFAOYSA-N 0.000 claims 3
- 125000002393 azetidinyl group Chemical group 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 208000037976 chronic inflammation Diseases 0.000 claims 3
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 3
- 125000003566 oxetanyl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims 3
- 125000002873 tetrahydrofuranonyl group Chemical group 0.000 claims 3
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 2
- AQSMJIUDASXMAR-UHFFFAOYSA-N 2-[1-methyl-2-oxo-5-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)pyridin-3-yl]-N-propylacetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C1)C)=O)CC(=O)NCCC AQSMJIUDASXMAR-UHFFFAOYSA-N 0.000 claims 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 2
- JLAKCHGEEBPDQI-UHFFFAOYSA-N 4-(4-fluorobenzyl)piperidine Chemical compound C1=CC(F)=CC=C1CC1CCNCC1 JLAKCHGEEBPDQI-UHFFFAOYSA-N 0.000 claims 2
- QBRQIZGNVWNBAA-UHFFFAOYSA-N C(C(C)C)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)C1=CC=CC=C1)C(C)C Chemical compound C(C(C)C)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)C1=CC=CC=C1)C(C)C QBRQIZGNVWNBAA-UHFFFAOYSA-N 0.000 claims 2
- SDSIMFLSAJRWTR-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)C)C=1C=C(C(N(C=1)C)=O)COC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)C)C=1C=C(C(N(C=1)C)=O)COC SDSIMFLSAJRWTR-UHFFFAOYSA-N 0.000 claims 2
- WSNRYBOPZWSTNW-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=CC=1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=CC=1 WSNRYBOPZWSTNW-UHFFFAOYSA-N 0.000 claims 2
- RSWWYUHUUJDLCR-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 RSWWYUHUUJDLCR-UHFFFAOYSA-N 0.000 claims 2
- LGDZEYQNBLSRGJ-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCOCC1)C=1C=C(C(N(C=1)C)=O)OC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCOCC1)C=1C=C(C(N(C=1)C)=O)OC LGDZEYQNBLSRGJ-UHFFFAOYSA-N 0.000 claims 2
- OHODETJGDSQAOZ-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C=1C=C(C(N(C=1)C)=O)COC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C=1C=C(C(N(C=1)C)=O)COC OHODETJGDSQAOZ-UHFFFAOYSA-N 0.000 claims 2
- JTLDUKMCPGRZAX-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C=1C=CC(N(C=1)C)=O Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C=1C=CC(N(C=1)C)=O JTLDUKMCPGRZAX-UHFFFAOYSA-N 0.000 claims 2
- ANGFFYTYKIHXLA-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CC1CCOCC1)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CC1CCOCC1)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 ANGFFYTYKIHXLA-UHFFFAOYSA-N 0.000 claims 2
- REOSUJNOZBGDRT-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C1=CC=NC=C1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C1=CC=NC=C1 REOSUJNOZBGDRT-UHFFFAOYSA-N 0.000 claims 2
- OUIJYCZIDWGTRY-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC(=CC=1)N1CCOCC1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC(=CC=1)N1CCOCC1 OUIJYCZIDWGTRY-UHFFFAOYSA-N 0.000 claims 2
- CBHLEIOBGMCFSL-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC(=NC=1)OC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC(=NC=1)OC CBHLEIOBGMCFSL-UHFFFAOYSA-N 0.000 claims 2
- AXVONYGIBFYVGI-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC=CC=1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC=CC=1 AXVONYGIBFYVGI-UHFFFAOYSA-N 0.000 claims 2
- RGQGSOPGTLUBRE-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCOC)C=1C=C(C(N(C=1)C)=O)C=1C=NN(C=1)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCOC)C=1C=C(C(N(C=1)C)=O)C=1C=NN(C=1)C RGQGSOPGTLUBRE-UHFFFAOYSA-N 0.000 claims 2
- XSYAPLCABWDSNE-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCS(=O)(=O)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCS(=O)(=O)C)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 XSYAPLCABWDSNE-UHFFFAOYSA-N 0.000 claims 2
- HPNFWPRTPSALED-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C(=C(C(N(N=1)C)=O)C)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C(=C(C(N(N=1)C)=O)C)C HPNFWPRTPSALED-UHFFFAOYSA-N 0.000 claims 2
- SGADBWIWKXIMKT-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C(=CC(N(N=1)C)=O)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C(=CC(N(N=1)C)=O)C SGADBWIWKXIMKT-UHFFFAOYSA-N 0.000 claims 2
- WFRNBQFXLOOCOB-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)C1=CC=C(C=C1)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)C1=CC=C(C=C1)C WFRNBQFXLOOCOB-UHFFFAOYSA-N 0.000 claims 2
- QWHWYVUWZBJWOP-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)C1=CC=CC=C1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)C1=CC=CC=C1 QWHWYVUWZBJWOP-UHFFFAOYSA-N 0.000 claims 2
- CHDRJGZAYXAYRA-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)C=1C(=NC=CC=1)OC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)C=1C(=NC=CC=1)OC CHDRJGZAYXAYRA-UHFFFAOYSA-N 0.000 claims 2
- FNJCPHWBYIZBMR-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)OC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C=1)C)=O)OC FNJCPHWBYIZBMR-UHFFFAOYSA-N 0.000 claims 2
- PNRHAPUIMZHBDK-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(N=1)C)=O)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(N=1)C)=O)C PNRHAPUIMZHBDK-UHFFFAOYSA-N 0.000 claims 2
- IQZAUIZBDKXPBH-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=CC(N(C=1)C)=O Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=CC(N(C=1)C)=O IQZAUIZBDKXPBH-UHFFFAOYSA-N 0.000 claims 2
- VDUBWVCWDWCSCZ-UHFFFAOYSA-N C(C)(C)C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound C(C)(C)C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O VDUBWVCWDWCSCZ-UHFFFAOYSA-N 0.000 claims 2
- GTYKPPYNNGJJHI-UHFFFAOYSA-N C(C)(C)N1C(C=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)=O Chemical compound C(C)(C)N1C(C=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)=O GTYKPPYNNGJJHI-UHFFFAOYSA-N 0.000 claims 2
- KREPENQKWLPKTL-UHFFFAOYSA-N C(C)C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound C(C)C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O KREPENQKWLPKTL-UHFFFAOYSA-N 0.000 claims 2
- ICDCUEPZOOXJDT-UHFFFAOYSA-N C(C)N1N=C(C(=C(C1=O)C)C)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1 Chemical compound C(C)N1N=C(C(=C(C1=O)C)C)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1 ICDCUEPZOOXJDT-UHFFFAOYSA-N 0.000 claims 2
- BEWVLZDZQMRPDD-UHFFFAOYSA-N C(C)N1N=C(C=C(C1=O)C)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1 Chemical compound C(C)N1N=C(C=C(C1=O)C)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1 BEWVLZDZQMRPDD-UHFFFAOYSA-N 0.000 claims 2
- ORKYVDRYSILTKJ-UHFFFAOYSA-N C(CC(C)C)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)C1=CC=CC=C1)C(C)C Chemical compound C(CC(C)C)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)C1=CC=CC=C1)C(C)C ORKYVDRYSILTKJ-UHFFFAOYSA-N 0.000 claims 2
- FBYGPAUZQIZKGK-VOTSOKGWSA-N C1(CC1)/C=C/C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound C1(CC1)/C=C/C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O FBYGPAUZQIZKGK-VOTSOKGWSA-N 0.000 claims 2
- SHRUUASWFAEHMT-UHFFFAOYSA-N C1(CC1)CCC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound C1(CC1)CCC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O SHRUUASWFAEHMT-UHFFFAOYSA-N 0.000 claims 2
- VFHVSZYXBMRKJO-UHFFFAOYSA-N CC(C)C(O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C(O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1 VFHVSZYXBMRKJO-UHFFFAOYSA-N 0.000 claims 2
- WYSNCXMVMSGKEL-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N(C)C)CC1)C1=CN(C)C(=O)C(=C1)C1=CC=CC=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N(C)C)CC1)C1=CN(C)C(=O)C(=C1)C1=CC=CC=C1 WYSNCXMVMSGKEL-UHFFFAOYSA-N 0.000 claims 2
- GJZIVZZJRYCCSG-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N(C)C)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N(C)C)CC1)C1=CN(C)C(=O)C(C)=C1 GJZIVZZJRYCCSG-UHFFFAOYSA-N 0.000 claims 2
- DPWODRJTDQRDDR-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N(C)C)CC1)C1=NN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N(C)C)CC1)C1=NN(C)C(=O)C(C)=C1 DPWODRJTDQRDDR-UHFFFAOYSA-N 0.000 claims 2
- FZMJWJNRKWMMDJ-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N2CCC(=O)N2)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(=O)N2CCC(=O)N2)CC1)C1=CN(C)C(=O)C(C)=C1 FZMJWJNRKWMMDJ-UHFFFAOYSA-N 0.000 claims 2
- MJTIMBYJKKKJIK-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(C)(C)O)CC1)C1=CN(C)C(=O)C(C)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(C)(C)O)CC1)C1=CN(C)C(=O)C(C)=C1C MJTIMBYJKKKJIK-UHFFFAOYSA-N 0.000 claims 2
- HTAOYTUKGACAMN-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(C)(C)O)CC1)C1=CN(CC2=CC=CC=C2)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(C)(C)O)CC1)C1=CN(CC2=CC=CC=C2)C(=O)C(C)=C1 HTAOYTUKGACAMN-UHFFFAOYSA-N 0.000 claims 2
- FHEJEGCINZHZJJ-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(O)C(C)(C)C)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(O)C(C)(C)C)CC1)C1=CN(C)C(=O)C(C)=C1 FHEJEGCINZHZJJ-UHFFFAOYSA-N 0.000 claims 2
- DZMDPBDZMOFMMM-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)C(C)(C)N)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)C(C)(C)N)C1=CN(C)C(=O)C(C)=C1 DZMDPBDZMOFMMM-UHFFFAOYSA-N 0.000 claims 2
- YIXODNBDLGLBOY-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)C1(N)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)C1(N)CC1)C1=CN(C)C(=O)C(C)=C1 YIXODNBDLGLBOY-UHFFFAOYSA-N 0.000 claims 2
- KFEKRZQATNIHHN-HSZRJFAPSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)C[C@H]1CCCN1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)C[C@H]1CCCN1)C1=CN(C)C(=O)C(C)=C1 KFEKRZQATNIHHN-HSZRJFAPSA-N 0.000 claims 2
- DKWDUKODESZDRF-QPPBQGQZSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)[C@@H]1C[C@@H](O)CN1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)[C@@H]1C[C@@H](O)CN1)C1=CN(C)C(=O)C(C)=C1 DKWDUKODESZDRF-QPPBQGQZSA-N 0.000 claims 2
- IUUKDKLTUBSIPP-RDGATRHJSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)[C@@H]1C[C@@H](O)CN1C)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)[C@@H]1C[C@@H](O)CN1C)C1=CN(C)C(=O)C(C)=C1 IUUKDKLTUBSIPP-RDGATRHJSA-N 0.000 claims 2
- DKWDUKODESZDRF-XUZZJYLKSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)[C@H]1C[C@H](O)CN1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(=O)[C@H]1C[C@H](O)CN1)C1=CN(C)C(=O)C(C)=C1 DKWDUKODESZDRF-XUZZJYLKSA-N 0.000 claims 2
- XPTIRUUYOOVBKC-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)(C)C(N)=O)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)(C)C(N)=O)C1=CN(C)C(=O)C(C)=C1 XPTIRUUYOOVBKC-UHFFFAOYSA-N 0.000 claims 2
- SMXODWZIORISFH-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCC(CC1)C(C)(C)O)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCC(CC1)C(C)(C)O)C1=CN(C)C(=O)C(C)=C1 SMXODWZIORISFH-UHFFFAOYSA-N 0.000 claims 2
- YLPQCQCOHZVLQT-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCC(F)(F)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCC(F)(F)CC1)C1=CN(C)C(=O)C(C)=C1 YLPQCQCOHZVLQT-UHFFFAOYSA-N 0.000 claims 2
- DEJDDBVJKBVUHN-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCN(C)C1=O)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCN(C)C1=O)C1=CN(C)C(=O)C(C)=C1 DEJDDBVJKBVUHN-UHFFFAOYSA-N 0.000 claims 2
- TUTKYYXVQSYKII-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCOC1)C1=CN(C)C(=O)C(C)=N1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCOC1)C1=CN(C)C(=O)C(C)=N1 TUTKYYXVQSYKII-UHFFFAOYSA-N 0.000 claims 2
- ZLHBOFFYGQOVSX-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=C(C)N(C)C(=O)C(=C1)C#N Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=C(C)N(C)C(=O)C(=C1)C#N ZLHBOFFYGQOVSX-UHFFFAOYSA-N 0.000 claims 2
- YFJLUXHVORBLRB-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=C(C)N(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=C(C)N(C)C(=O)C(C)=C1 YFJLUXHVORBLRB-UHFFFAOYSA-N 0.000 claims 2
- KIVMKJFHBPRNSL-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=CN(C)C(=O)C(C)=C1 KIVMKJFHBPRNSL-UHFFFAOYSA-N 0.000 claims 2
- WKPBDBQZTVGBPO-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=CN(C)C(=O)C(C)=N1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=CN(C)C(=O)C(C)=N1 WKPBDBQZTVGBPO-UHFFFAOYSA-N 0.000 claims 2
- WEQFIIVECRDCCZ-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1COC1)C1=CN(C)C(=O)C(Cl)=C1C WEQFIIVECRDCCZ-UHFFFAOYSA-N 0.000 claims 2
- JXDCCTHLYDEERE-HSZRJFAPSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)[C@@H]1CCNC1=O)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)[C@@H]1CCNC1=O)C1=CN(C)C(=O)C(C)=C1 JXDCCTHLYDEERE-HSZRJFAPSA-N 0.000 claims 2
- MRSMKJUCZJRDJL-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=C(F)C=CC(OC(F)F)=C2)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=C(F)C=CC(OC(F)F)=C2)CC1)C1=CN(C)C(=O)C(C)=C1 MRSMKJUCZJRDJL-UHFFFAOYSA-N 0.000 claims 2
- XMOXNHQNUABGHE-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=CC=C(OC(F)(F)F)C=C2)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=CC=C(OC(F)(F)F)C=C2)CC1)C1=CN(C)C(=O)C(C)=C1 XMOXNHQNUABGHE-UHFFFAOYSA-N 0.000 claims 2
- RAODKAUDOHGIOY-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=CN(C)N=C2C)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=CN(C)N=C2C)CC1)C1=CN(C)C(=O)C(C)=C1 RAODKAUDOHGIOY-UHFFFAOYSA-N 0.000 claims 2
- NBYCGTLLWPRVTP-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=NC=NN2C)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=NC=NN2C)CC1)C1=CN(C)C(=O)C(C)=C1 NBYCGTLLWPRVTP-UHFFFAOYSA-N 0.000 claims 2
- RKQDVIFQGAUPKA-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=NN(C)C=N2)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2=NN(C)C=N2)CC1)C1=CN(C)C(=O)C(C)=C1 RKQDVIFQGAUPKA-UHFFFAOYSA-N 0.000 claims 2
- JTEGOTPZIRTKTN-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2CC2)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC2CC2)CC1)C1=CN(C)C(=O)C(C)=C1 JTEGOTPZIRTKTN-UHFFFAOYSA-N 0.000 claims 2
- BTWLZKJFNRARRF-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CCC(C(F)(F)F)C(F)(F)F)CC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CCC(C(F)(F)F)C(F)(F)F)CC1)C1=CN(C)C(=O)C(C)=C1 BTWLZKJFNRARRF-UHFFFAOYSA-N 0.000 claims 2
- HIVOYUWZAQKJOI-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CCC(C)(C)O)CC1)C1=CN(C)C(=O)C(C)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CCC(C)(C)O)CC1)C1=CN(C)C(=O)C(C)=C1C HIVOYUWZAQKJOI-UHFFFAOYSA-N 0.000 claims 2
- WTGCZRCSZPHDHB-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=C(C)N(C)C(=O)C(=C1)C#N Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=C(C)N(C)C(=O)C(=C1)C#N WTGCZRCSZPHDHB-UHFFFAOYSA-N 0.000 claims 2
- KBLVOIWGLDSCIG-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(=C1)C#N Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(=C1)C#N KBLVOIWGLDSCIG-UHFFFAOYSA-N 0.000 claims 2
- UJYZQNRNPIEBQX-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(=C1)C1=CC=CC(=C1)C#N Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(=C1)C1=CC=CC(=C1)C#N UJYZQNRNPIEBQX-UHFFFAOYSA-N 0.000 claims 2
- MDJOLQJIRPJAEJ-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(C)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(C)=C1C MDJOLQJIRPJAEJ-UHFFFAOYSA-N 0.000 claims 2
- WBWUDRDCOAHSRK-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(C2=CC=CN=C2)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(C2=CC=CN=C2)=C1C WBWUDRDCOAHSRK-UHFFFAOYSA-N 0.000 claims 2
- XWDYTRZBWFUHFC-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(N)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C(N)=C1C XWDYTRZBWFUHFC-UHFFFAOYSA-N 0.000 claims 2
- NIFHQFDMNPVZIY-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(C)C(=O)C=C1C NIFHQFDMNPVZIY-UHFFFAOYSA-N 0.000 claims 2
- BSEJLWNXBAFLCD-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(CC(C)(C)O)C(=O)C=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(CC(C)(C)O)C(=O)C=C1 BSEJLWNXBAFLCD-UHFFFAOYSA-N 0.000 claims 2
- MMSHTFUELICICG-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(CC(F)F)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(CC(F)F)C(=O)C(C)=C1 MMSHTFUELICICG-UHFFFAOYSA-N 0.000 claims 2
- YZIVKSIWNCZCBL-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(CC2=CC=CC=C2)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C1=CN(CC2=CC=CC=C2)C(=O)C(C)=C1 YZIVKSIWNCZCBL-UHFFFAOYSA-N 0.000 claims 2
- SDRXVHVOMGFMNW-UHFFFAOYSA-N CC(C)CCN1CCC(CC1)c1ccc2[nH]c(c(C(C)C)c2c1)-c1cn(C)c(=O)c(Cl)c1C Chemical compound CC(C)CCN1CCC(CC1)c1ccc2[nH]c(c(C(C)C)c2c1)-c1cn(C)c(=O)c(Cl)c1C SDRXVHVOMGFMNW-UHFFFAOYSA-N 0.000 claims 2
- HZDZRDLZMFOIIK-UHFFFAOYSA-N CC(C)CN1C=C(C=C(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCN(CC(=O)N(C)C)CC1 Chemical compound CC(C)CN1C=C(C=C(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCN(CC(=O)N(C)C)CC1 HZDZRDLZMFOIIK-UHFFFAOYSA-N 0.000 claims 2
- CMNUEMGOSNIADQ-UHFFFAOYSA-N CC(C)CN1C=C(C=C(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 Chemical compound CC(C)CN1C=C(C=C(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 CMNUEMGOSNIADQ-UHFFFAOYSA-N 0.000 claims 2
- JSWHHTXLLDBKSM-UHFFFAOYSA-N CC(C)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1 JSWHHTXLLDBKSM-UHFFFAOYSA-N 0.000 claims 2
- ANJRZJXIENGDDR-UHFFFAOYSA-N CC(C)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CC(C)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C ANJRZJXIENGDDR-UHFFFAOYSA-N 0.000 claims 2
- KOKSFWQGKUUSHY-UHFFFAOYSA-N CC(C)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(CC(C)C)C(=O)C(C)=C1 Chemical compound CC(C)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(CC(C)C)C(=O)C(C)=C1 KOKSFWQGKUUSHY-UHFFFAOYSA-N 0.000 claims 2
- HJKIXMZZXQOMQS-UHFFFAOYSA-N CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=C(C)N(C)C(=O)C(C)=C1 Chemical compound CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=C(C)N(C)C(=O)C(C)=C1 HJKIXMZZXQOMQS-UHFFFAOYSA-N 0.000 claims 2
- IWIHTKGNAYGUSH-UHFFFAOYSA-N CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC(C)=C(F)N=C1 Chemical compound CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC(C)=C(F)N=C1 IWIHTKGNAYGUSH-UHFFFAOYSA-N 0.000 claims 2
- ZKPVXZRCODLNDA-UHFFFAOYSA-N CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC=CN=C1 Chemical compound CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC=CN=C1 ZKPVXZRCODLNDA-UHFFFAOYSA-N 0.000 claims 2
- SGOGTJBUNWKKDE-UHFFFAOYSA-N CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1C Chemical compound CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1C SGOGTJBUNWKKDE-UHFFFAOYSA-N 0.000 claims 2
- IQROJXLFTNFSIB-UHFFFAOYSA-N CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=N1 Chemical compound CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=N1 IQROJXLFTNFSIB-UHFFFAOYSA-N 0.000 claims 2
- LCDJTNTUCJDMQE-UHFFFAOYSA-N CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C LCDJTNTUCJDMQE-UHFFFAOYSA-N 0.000 claims 2
- ACHGMFQHVQCOBK-UHFFFAOYSA-N CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC1)C(=O)CN(C)C)-c1cc(C#N)c(=O)n(C)c1C Chemical compound CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC1)C(=O)CN(C)C)-c1cc(C#N)c(=O)n(C)c1C ACHGMFQHVQCOBK-UHFFFAOYSA-N 0.000 claims 2
- FAICUBOFCILGFU-UHFFFAOYSA-N CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC1)C(=O)CN(C)C)-c1cc(C)c(=O)n(Cc2ccccc2)c1 Chemical compound CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC1)C(=O)CN(C)C)-c1cc(C)c(=O)n(Cc2ccccc2)c1 FAICUBOFCILGFU-UHFFFAOYSA-N 0.000 claims 2
- XLMOXIUSKTVYNQ-UHFFFAOYSA-N CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC1)C(=O)CN(C)C)-c1cn(C)c(=O)c(C#N)c1C Chemical compound CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC1)C(=O)CN(C)C)-c1cn(C)c(=O)c(C#N)c1C XLMOXIUSKTVYNQ-UHFFFAOYSA-N 0.000 claims 2
- YOPHGOOIQXTRSA-UHFFFAOYSA-N CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(C)c(=O)n(CCCO)c1 Chemical compound CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1cc(C)c(=O)n(CCCO)c1 YOPHGOOIQXTRSA-UHFFFAOYSA-N 0.000 claims 2
- SILLCSGOEQCVIF-UHFFFAOYSA-N CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1ccc(=O)n(C)c1C Chemical compound CC(C)c1c([nH]c2ccc(cc12)C1CCNCC1)-c1ccc(=O)n(C)c1C SILLCSGOEQCVIF-UHFFFAOYSA-N 0.000 claims 2
- WRWJDOLDRUMQCE-UHFFFAOYSA-N CC(CCC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O)(C)C Chemical compound CC(CCC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O)(C)C WRWJDOLDRUMQCE-UHFFFAOYSA-N 0.000 claims 2
- SYCUFKHBAMGLLH-UHFFFAOYSA-N CCC1=CC(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCNCC2)=C(C)N(C)C1=O Chemical compound CCC1=CC(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCNCC2)=C(C)N(C)C1=O SYCUFKHBAMGLLH-UHFFFAOYSA-N 0.000 claims 2
- UWHKIGOVDGJNAB-UHFFFAOYSA-N CCCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CCCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C UWHKIGOVDGJNAB-UHFFFAOYSA-N 0.000 claims 2
- JMZFOQPLNCDFBG-UHFFFAOYSA-N CCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC(C)=CN=C1 Chemical compound CCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC(C)=CN=C1 JMZFOQPLNCDFBG-UHFFFAOYSA-N 0.000 claims 2
- UFQASAXUFMELMV-UHFFFAOYSA-N CCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CN=CN=C1 Chemical compound CCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CN=CN=C1 UFQASAXUFMELMV-UHFFFAOYSA-N 0.000 claims 2
- QDVBHKKAASOSHK-UHFFFAOYSA-N CCN1C(C)=C(C=C(CC)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 Chemical compound CCN1C(C)=C(C=C(CC)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 QDVBHKKAASOSHK-UHFFFAOYSA-N 0.000 claims 2
- QOSMGUMPKXEYHG-UHFFFAOYSA-N CCN1C=C(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCN(CC2)C(C)C)C(C)=C(C)C1=O Chemical compound CCN1C=C(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCN(CC2)C(C)C)C(C)=C(C)C1=O QOSMGUMPKXEYHG-UHFFFAOYSA-N 0.000 claims 2
- CKXFXTPHPHUUJP-UHFFFAOYSA-N CCN1C=C(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCN(CC2)C2COC2)C(C)=C(C)C1=O Chemical compound CCN1C=C(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCN(CC2)C2COC2)C(C)=C(C)C1=O CKXFXTPHPHUUJP-UHFFFAOYSA-N 0.000 claims 2
- DXXJCNPLMRMBOB-UHFFFAOYSA-N CCN1C=C(C=C(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 Chemical compound CCN1C=C(C=C(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 DXXJCNPLMRMBOB-UHFFFAOYSA-N 0.000 claims 2
- FKHYXXHDDLSTGS-UHFFFAOYSA-N CCNC(=O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CCNC(=O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C FKHYXXHDDLSTGS-UHFFFAOYSA-N 0.000 claims 2
- YPKLTJNUODTQSB-UHFFFAOYSA-N CCc1cc(cn(CC)c1=O)-c1[nH]c2ccc(cc2c1C(C)C)C1CCNCC1 Chemical compound CCc1cc(cn(CC)c1=O)-c1[nH]c2ccc(cc2c1C(C)C)C1CCNCC1 YPKLTJNUODTQSB-UHFFFAOYSA-N 0.000 claims 2
- NDRWBFPBYSWTHC-UHFFFAOYSA-N CN(CC(=O)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)COC)C(C)C)C Chemical compound CN(CC(=O)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)COC)C(C)C)C NDRWBFPBYSWTHC-UHFFFAOYSA-N 0.000 claims 2
- LKXPZIAWZSXNIJ-UHFFFAOYSA-N CN(CC(=O)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)OC)C(C)C)C Chemical compound CN(CC(=O)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)OC)C(C)C)C LKXPZIAWZSXNIJ-UHFFFAOYSA-N 0.000 claims 2
- CIUJKGGOIQRVQE-UHFFFAOYSA-N CN(CC(=O)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)CCOC)=O)C)C(C)C)C Chemical compound CN(CC(=O)N1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)CCOC)=O)C)C(C)C)C CIUJKGGOIQRVQE-UHFFFAOYSA-N 0.000 claims 2
- QLUYHMAIZBGBAW-UHFFFAOYSA-N CNC(=O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=C(C)N(C)C(=O)C(=C1)C#N Chemical compound CNC(=O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=C(C)N(C)C(=O)C(=C1)C#N QLUYHMAIZBGBAW-UHFFFAOYSA-N 0.000 claims 2
- YFAHLMCTUWAOMN-UHFFFAOYSA-N CNC(=O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1C Chemical compound CNC(=O)CN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1C YFAHLMCTUWAOMN-UHFFFAOYSA-N 0.000 claims 2
- LUBMNCIZVJZWTI-UHFFFAOYSA-N CNC(C)(C)C(=O)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CNC(C)(C)C(=O)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1 LUBMNCIZVJZWTI-UHFFFAOYSA-N 0.000 claims 2
- LBWVZINQDMMCRV-UHFFFAOYSA-N COC(=O)C1=CC(=CN(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 Chemical compound COC(=O)C1=CC(=CN(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCNCC1 LBWVZINQDMMCRV-UHFFFAOYSA-N 0.000 claims 2
- LRYGGBYVMWJIAW-UHFFFAOYSA-N COC1=CC(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCN(CC2)C2COC2)=C(C)N(C)C1=O Chemical compound COC1=CC(C2=C(C(C)C)C3=CC(=CC=C3N2)C2CCN(CC2)C2COC2)=C(C)N(C)C1=O LRYGGBYVMWJIAW-UHFFFAOYSA-N 0.000 claims 2
- FYGUWGGYJLBXEH-UHFFFAOYSA-N COCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC=C(C)N=C1 Chemical compound COCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC=C(C)N=C1 FYGUWGGYJLBXEH-UHFFFAOYSA-N 0.000 claims 2
- UCLNYKOCVNUPSI-UHFFFAOYSA-N COCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound COCCN1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(Cl)=C1C UCLNYKOCVNUPSI-UHFFFAOYSA-N 0.000 claims 2
- QENPVZKZFVPCLZ-UHFFFAOYSA-N COCCn1cc(cc(C)c1=O)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N(C)C)CC1 Chemical compound COCCn1cc(cc(C)c1=O)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N(C)C)CC1 QENPVZKZFVPCLZ-UHFFFAOYSA-N 0.000 claims 2
- GFCUPHKSCWWTML-UHFFFAOYSA-N COc1cc(-c2[nH]c3ccc(cc3c2C(C)C)C2CCN(CC2)C(=O)CN(C)C)c(C)n(C)c1=O Chemical compound COc1cc(-c2[nH]c3ccc(cc3c2C(C)C)C2CCN(CC2)C(=O)CN(C)C)c(C)n(C)c1=O GFCUPHKSCWWTML-UHFFFAOYSA-N 0.000 claims 2
- ZKNIVOLTHVFFCU-UHFFFAOYSA-N ClC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound ClC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O ZKNIVOLTHVFFCU-UHFFFAOYSA-N 0.000 claims 2
- YZQLLHSSQSYSFP-UHFFFAOYSA-N FC1=C2C(=C(NC2=CC=C1C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1)C(C)C Chemical compound FC1=C2C(=C(NC2=CC=C1C1CCN(CC1)CCC)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1)C(C)C YZQLLHSSQSYSFP-UHFFFAOYSA-N 0.000 claims 2
- HTOVANYLMPNSSH-UHFFFAOYSA-N FC1=CC=C(C=N1)C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCN(CC1)C(C)C)C)=O Chemical compound FC1=CC=C(C=N1)C=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCN(CC1)C(C)C)C)=O HTOVANYLMPNSSH-UHFFFAOYSA-N 0.000 claims 2
- NGRMYPOSYPOHKW-UHFFFAOYSA-N FC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound FC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O NGRMYPOSYPOHKW-UHFFFAOYSA-N 0.000 claims 2
- HJFRYUBEDSOGKV-UHFFFAOYSA-N N,N-dimethyl-2-[1-methyl-2-oxo-5-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)pyridin-3-yl]acetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCNCC1)C=1C=C(C(N(C1)C)=O)CC(=O)N(C)C HJFRYUBEDSOGKV-UHFFFAOYSA-N 0.000 claims 2
- SMLCMZPZOLSWDC-UHFFFAOYSA-N NC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound NC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O SMLCMZPZOLSWDC-UHFFFAOYSA-N 0.000 claims 2
- SXBPOSARLBEZCR-UHFFFAOYSA-N OC(CN1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)CC(C)C)=O)C)C(C)C)(C)C Chemical compound OC(CN1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)CC(C)C)=O)C)C(C)C)(C)C SXBPOSARLBEZCR-UHFFFAOYSA-N 0.000 claims 2
- PIYTTYGQOKZIDI-UHFFFAOYSA-N OCC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound OCC=1C(N(C=C(C=1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O PIYTTYGQOKZIDI-UHFFFAOYSA-N 0.000 claims 2
- MTFHOZSZQAEDMI-UHFFFAOYSA-N OCCN1C(C(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O Chemical compound OCCN1C(C(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCNCC1)C)=O MTFHOZSZQAEDMI-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 claims 2
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 claims 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 claims 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 2
- NXQOUXZNQJEEIJ-UHFFFAOYSA-N 1,4-dimethyl-2-oxopyridine-3-carbonitrile Chemical compound CC=1C=CN(C)C(=O)C=1C#N NXQOUXZNQJEEIJ-UHFFFAOYSA-N 0.000 claims 1
- GZHMVYGTUDWGOJ-UHFFFAOYSA-N 1-(4,4,4-trifluorobutyl)piperidine Chemical compound FC(F)(F)CCCN1CCCCC1 GZHMVYGTUDWGOJ-UHFFFAOYSA-N 0.000 claims 1
- SAPDHAIDOPKGHW-UHFFFAOYSA-N 1-(oxan-4-yl)piperidine Chemical compound C1CCCCN1C1CCOCC1 SAPDHAIDOPKGHW-UHFFFAOYSA-N 0.000 claims 1
- NFYZJKOJCRMDRO-UHFFFAOYSA-N 1-(oxetan-3-yl)piperidine Chemical compound C1OCC1N1CCCCC1 NFYZJKOJCRMDRO-UHFFFAOYSA-N 0.000 claims 1
- VTDIWMPYBAVEDY-UHFFFAOYSA-N 1-propylpiperidine Chemical compound CCCN1CCCCC1 VTDIWMPYBAVEDY-UHFFFAOYSA-N 0.000 claims 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 claims 1
- DMORLWUYAVTAPC-UHFFFAOYSA-N 2-(dimethylamino)-1-piperidin-1-ylethanone Chemical compound CN(C)CC(=O)N1CCCCC1 DMORLWUYAVTAPC-UHFFFAOYSA-N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- SSBJNXYJAHFKJQ-UHFFFAOYSA-N 2-methyl-1-piperidin-1-ylpropan-2-ol Chemical compound CC(C)(O)CN1CCCCC1 SSBJNXYJAHFKJQ-UHFFFAOYSA-N 0.000 claims 1
- LNJMHEJAYSYZKK-UHFFFAOYSA-N 2-methylpyrimidine Chemical compound CC1=NC=CC=N1 LNJMHEJAYSYZKK-UHFFFAOYSA-N 0.000 claims 1
- HLACCWZATOVISE-UHFFFAOYSA-N 2-propan-2-yl-1H-pyridazine Chemical compound CC(C)N1NC=CC=C1 HLACCWZATOVISE-UHFFFAOYSA-N 0.000 claims 1
- GJELDSCPTNJBFL-UHFFFAOYSA-N 3-chloro-1,4-dimethylpyridin-2-one Chemical compound Cc1ccn(C)c(=O)c1Cl GJELDSCPTNJBFL-UHFFFAOYSA-N 0.000 claims 1
- OFDVABAUFQJWEZ-UHFFFAOYSA-N 3-pyridin-3-ylpyridine Chemical compound C1=CN=CC(C=2C=NC=CC=2)=C1 OFDVABAUFQJWEZ-UHFFFAOYSA-N 0.000 claims 1
- ZTMXVCKXKBNQCY-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCOC)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)CCOC)C=1C=C(C(N(C=1)C)=O)C=1C=NC=NC=1 ZTMXVCKXKBNQCY-UHFFFAOYSA-N 0.000 claims 1
- ZEAPVYLDYDNKKL-UHFFFAOYSA-N CC(C)C1=C(C(C=C2C#N)=C(C)N(C)C2=O)NC2=CC=CC=C12 Chemical compound CC(C)C1=C(C(C=C2C#N)=C(C)N(C)C2=O)NC2=CC=CC=C12 ZEAPVYLDYDNKKL-UHFFFAOYSA-N 0.000 claims 1
- VFILASBCHHSZNH-UHFFFAOYSA-N CC(C)C1=C(C(C=C2C)=CN(CC3=CC=CC=C3)C2=O)NC2=CC=CC=C12 Chemical compound CC(C)C1=C(C(C=C2C)=CN(CC3=CC=CC=C3)C2=O)NC2=CC=CC=C12 VFILASBCHHSZNH-UHFFFAOYSA-N 0.000 claims 1
- MBHRCJNMILRMEJ-UHFFFAOYSA-N CC(C)C1=C(C(C=C2OC)=CN(C)C2=O)NC2=CC=CC=C12 Chemical compound CC(C)C1=C(C(C=C2OC)=CN(C)C2=O)NC2=CC=CC=C12 MBHRCJNMILRMEJ-UHFFFAOYSA-N 0.000 claims 1
- BJTVBNMOQDYPII-UHFFFAOYSA-N CC(C)C1=C(C2=CN(C)NC(C)=C2)NC2=CC=C(C3CCNCC3)C=C12 Chemical compound CC(C)C1=C(C2=CN(C)NC(C)=C2)NC2=CC=C(C3CCNCC3)C=C12 BJTVBNMOQDYPII-UHFFFAOYSA-N 0.000 claims 1
- DFSHOADIORZBHR-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(C)CC1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(C)CC1)C1=CN(C)C(=O)C(Cl)=C1C DFSHOADIORZBHR-UHFFFAOYSA-N 0.000 claims 1
- QEGADFWJXCOAFR-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(C)(C)O)CC1)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(C)(C)O)CC1)C1=CN(C)C(=O)C(Cl)=C1C QEGADFWJXCOAFR-UHFFFAOYSA-N 0.000 claims 1
- NPUOUPYXRZWHKH-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)=O)C1=CN(C)C(=O)C(Cl)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C(C)=O)C1=CN(C)C(=O)C(Cl)=C1C NPUOUPYXRZWHKH-UHFFFAOYSA-N 0.000 claims 1
- FKDNBPCBKXEFMR-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCCCC1)C1=CN(C)C(=O)C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC1)C1CCCCC1)C1=CN(C)C(=O)C(C)=C1 FKDNBPCBKXEFMR-UHFFFAOYSA-N 0.000 claims 1
- DGXPAHSQMQWTCS-UHFFFAOYSA-N CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC=CN=C1C Chemical compound CC(C)N1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(=C1)C1=CC=CN=C1C DGXPAHSQMQWTCS-UHFFFAOYSA-N 0.000 claims 1
- MEWAYOUFYMZAIL-UHFFFAOYSA-N CN1C=C(C=C(C1=O)C)C=1NC2=CC=CC=C2C1C(C)C Chemical compound CN1C=C(C=C(C1=O)C)C=1NC2=CC=CC=C2C1C(C)C MEWAYOUFYMZAIL-UHFFFAOYSA-N 0.000 claims 1
- GPSGVZGEMXSGGQ-UHFFFAOYSA-N COC1=C(C)C(=CN(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCN(CC1)C1COC1 Chemical compound COC1=C(C)C(=CN(C)C1=O)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCN(CC1)C1COC1 GPSGVZGEMXSGGQ-UHFFFAOYSA-N 0.000 claims 1
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical compound CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical compound CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000003725 azepanyl group Chemical group 0.000 claims 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000000068 chlorophenyl group Chemical group 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000005959 diazepanyl group Chemical group 0.000 claims 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- DWYJHMSKXMHOAP-UHFFFAOYSA-N oxetan-2-ol Chemical compound OC1CCO1 DWYJHMSKXMHOAP-UHFFFAOYSA-N 0.000 claims 1
- 125000006299 oxetan-3-yl group Chemical group [H]C1([H])OC([H])([H])C1([H])* 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762541335P | 2017-08-04 | 2017-08-04 | |
| US62/541,335 | 2017-08-04 | ||
| PCT/US2018/045082 WO2019028302A1 (en) | 2017-08-04 | 2018-08-03 | SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR7 / 8/9 INHIBITORS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020529433A JP2020529433A (ja) | 2020-10-08 |
| JP2020529433A5 true JP2020529433A5 (https=) | 2021-09-09 |
| JP7104775B2 JP7104775B2 (ja) | 2022-07-21 |
Family
ID=63245105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505835A Active JP7104775B2 (ja) | 2017-08-04 | 2018-08-03 | Ｔｌｒ７／８／９の阻害剤として有用な置換インドール化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11447466B2 (https=) |
| EP (1) | EP3661926B1 (https=) |
| JP (1) | JP7104775B2 (https=) |
| KR (1) | KR102651947B1 (https=) |
| CN (1) | CN110997656B (https=) |
| ES (1) | ES2909401T3 (https=) |
| WO (1) | WO2019028302A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| MX2020005462A (es) * | 2017-12-19 | 2020-09-07 | Bristol Myers Squibb Co | Compuestos de indol sustituidos utiles como inhibidores de receptores tipo toll (tlr). |
| JP7328977B2 (ja) | 2018-02-12 | 2023-08-17 | エフ． ホフマン－ラ ロシュ アーゲー | ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体 |
| EP3802539B1 (en) | 2018-06-05 | 2023-09-20 | F. Hoffmann-La Roche AG | Tetrahydro-1h-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease |
| EP3807270B1 (en) | 2018-06-12 | 2023-09-13 | F. Hoffmann-La Roche AG | Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease |
| CN112584903B (zh) | 2018-07-23 | 2025-12-23 | 豪夫迈·罗氏有限公司 | 用于自身免疫性疾病治疗的哌嗪化合物 |
| EP3847169A1 (en) | 2018-09-04 | 2021-07-14 | F. Hoffmann-La Roche AG | Benzothiazole compounds for the treatment of autoimmune diseases |
| US11548884B2 (en) | 2018-09-06 | 2023-01-10 | Hoffmann-La Roche Inc. | Cyclic amidine compounds for the treatment of autoimmune disease |
| EP3847173B1 (en) | 2018-09-06 | 2023-04-12 | F. Hoffmann-La Roche AG | Novel pyrazolopyridine compounds for the treatment of autoimmune disease |
| WO2021084022A1 (en) | 2019-10-31 | 2021-05-06 | F. Hoffmann-La Roche Ag | Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease |
| CN114728976B (zh) | 2019-11-19 | 2024-08-16 | 豪夫迈·罗氏有限公司 | 用于治疗自身免疫性疾病的氢-1H-吡咯并[1,2-a]吡嗪化合物 |
| WO2021099406A1 (en) | 2019-11-20 | 2021-05-27 | F. Hoffmann-La Roche Ag | Spiro(isobenzofuranazetidine) compounds for the treatment of autoimmune disease |
| CN111747926B (zh) * | 2020-06-23 | 2024-01-30 | 浙江华海药业股份有限公司 | 一种羟哌吡酮游离碱的合成工艺改进方法 |
| CN116075510A (zh) | 2020-08-19 | 2023-05-05 | 百时美施贵宝公司 | 1H-苯并[d]咪唑衍生物作为TLR9抑制剂用于治疗纤维化 |
| AU2021328575A1 (en) | 2020-08-19 | 2023-03-16 | Bristol-Myers Squibb Company | Imidazo(1,2-a)pyridine and (1,2,4)triazolo(1,5-a)pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis |
| WO2022040267A1 (en) | 2020-08-19 | 2022-02-24 | Bristol-Myers Squibb Company | 1h-pyrrolo[3,2-c]pyridine and 1h-pyrrolo[2,3-c]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis |
| CN112430632B (zh) * | 2020-11-18 | 2022-09-13 | 上海合全药物研发有限公司 | 2-((反式)-4-氨基环己烷基)异丙醇的制备方法 |
| CR20230478A (es) | 2021-04-16 | 2023-11-30 | Gilead Sciences Inc | Compuestos de tienopirrol. |
| CN113604553B (zh) * | 2021-07-27 | 2023-08-15 | 中南大学湘雅二医院 | 成人still’s病生物标志物、诊断试剂及其应用 |
| KR20240056747A (ko) | 2021-09-10 | 2024-04-30 | 길리애드 사이언시즈, 인코포레이티드 | 티에노피롤 화합물 |
| CN114591339B (zh) * | 2022-05-10 | 2022-08-02 | 上海维申医药有限公司 | 一类Toll样受体抑制剂及其制备和应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000035886A2 (en) | 1998-12-18 | 2000-06-22 | Axys Pharmaceuticals, Inc. | (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors |
| BRPI0411514A (pt) | 2003-06-20 | 2006-08-01 | Coley Pharm Gmbh | antagonistas de receptor toll-like de molécula pequena |
| WO2006113458A1 (en) | 2005-04-15 | 2006-10-26 | Bristol-Myers Squibb Company | Heterocyclic inhibitors of protein arginine methyl transferases |
| CA2648652A1 (en) | 2006-04-04 | 2007-10-11 | Myriad Genetics, Inc. | Compounds for diseases and disorders |
| DE102006033109A1 (de) | 2006-07-18 | 2008-01-31 | Grünenthal GmbH | Substituierte Heteroaryl-Derivate |
| US8027888B2 (en) | 2006-08-31 | 2011-09-27 | Experian Interactive Innovation Center, Llc | Online credit card prescreen systems and methods |
| JP2010511018A (ja) | 2006-12-01 | 2010-04-08 | ガラパゴス・ナムローゼ・フェンノートシャップ | 変性疾患及び炎症性疾患の治療に有用なトリアゾロピリジン化合物 |
| WO2008152471A1 (en) | 2007-06-12 | 2008-12-18 | Coley Pharmaceutical Group, Inc. | Quinazoline derivative useful as toll-like receptor antagonist |
| WO2009030996A1 (en) | 2007-09-05 | 2009-03-12 | Coley Pharmaceutical Group, Inc. | Triazole compounds as toll-like receptor (tlr) agonists |
| FR2926556B1 (fr) | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique |
| WO2010036905A1 (en) | 2008-09-26 | 2010-04-01 | Eisai R & D Management Co., Ltd. | Benzoxazole compounds and methods of use |
| US8785489B2 (en) | 2008-10-17 | 2014-07-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as MMP-13 inhibitors |
| TWI462920B (zh) | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| JP5864417B2 (ja) | 2009-07-16 | 2016-02-17 | マリンクロッド エルエルシー | トール様受容体９のアンタゴニストとしての（＋）−モルフィナンおよびその治療的使用 |
| WO2012054862A2 (en) | 2010-10-21 | 2012-04-26 | The Brigham And Women's Hospital, Inc. | Agents, compositions, and methods for treating pruritis and related skin conditions |
| DK2663550T3 (en) | 2011-01-12 | 2017-03-27 | Ventirx Pharmaceuticals Inc | SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS |
| CN103562201B (zh) | 2011-01-12 | 2016-10-19 | 帆德制药股份有限公司 | 作为toll样受体调节剂的取代的苯并氮杂卓 |
| KR102052215B1 (ko) | 2011-06-01 | 2019-12-04 | 야누스 바이오테라퓨틱스, 인크. | 신규한 면역 시스템 조절제 |
| WO2012167053A1 (en) | 2011-06-01 | 2012-12-06 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| KR101913619B1 (ko) | 2011-06-09 | 2018-12-28 | 리젠 파마슈티컬스 소시에떼 아노님 | Gpr-119의 조절제로서의 신규한 화합물 |
| KR101913135B1 (ko) | 2011-07-15 | 2018-10-30 | 얀센 파마슈티칼즈, 인코포레이티드 | 감마 세크레타제 조절 인자로서의 신규의 치환 인돌 유도체 |
| WO2013052550A2 (en) | 2011-10-04 | 2013-04-11 | Janus Biotherapeutics, Inc. | Novel imidazole quinoline-based immune system modulators |
| TWI619704B (zh) | 2012-05-18 | 2018-04-01 | 大日本住友製藥股份有限公司 | 羧酸化合物 |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| US20150051208A1 (en) | 2013-08-14 | 2015-02-19 | Boehringer Ingelheim International Gmbh | Pyridinones |
| JP6223563B2 (ja) | 2013-10-14 | 2017-11-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 選択的に置換されたキノリン化合物 |
| CN105992766A (zh) * | 2013-12-13 | 2016-10-05 | 武田药品工业株式会社 | 作为tlr抑制剂的吡咯并[3,2-c]吡啶衍生物 |
| EP3398948A3 (en) | 2014-08-22 | 2018-12-05 | Janus Biotherapeutics, Inc. | 2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof |
| US9550778B2 (en) | 2014-10-03 | 2017-01-24 | Vanderbilt University | Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5 |
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| BR112019001270A2 (pt) | 2016-07-30 | 2019-04-30 | Bristol-Myers Squibb Company | compostos indol substituídos com dimetoxifenila como inibidores de tlr7, tlr8 ou tlr9 |
| JP7028861B2 (ja) * | 2016-09-09 | 2022-03-02 | ブリストル－マイヤーズ スクイブ カンパニー | ピリジル置換のインドール化合物 |
| KR102730859B1 (ko) * | 2017-12-20 | 2024-11-15 | 브리스톨-마이어스 스큅 컴퍼니 | 아릴 및 헤테로아릴 치환된 인돌 화합물 |
-
2018
- 2018-08-03 WO PCT/US2018/045082 patent/WO2019028302A1/en not_active Ceased
- 2018-08-03 US US16/635,593 patent/US11447466B2/en active Active
- 2018-08-03 EP EP18756116.2A patent/EP3661926B1/en active Active
- 2018-08-03 KR KR1020207005967A patent/KR102651947B1/ko active Active
- 2018-08-03 ES ES18756116T patent/ES2909401T3/es active Active
- 2018-08-03 JP JP2020505835A patent/JP7104775B2/ja active Active
- 2018-08-03 CN CN201880050864.0A patent/CN110997656B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020529433A5 (https=) | ||
| JP2019525941A5 (https=) | ||
| JP2019530667A5 (https=) | ||
| ES2346674T3 (es) | Compuestos heteroaromaticos de quinolina y su uso como inhibidores de pde10. | |
| KR101841003B1 (ko) | 신규한 소염제 | |
| ES2360741T3 (es) | Triazolil fenil bencenosulfonamidas. | |
| KR101566091B1 (ko) | Lrrk2 조절제로서 피라졸 아미노피리미딘 유도체 | |
| HRP20231730T1 (hr) | Fenilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene | |
| RU2581504C2 (ru) | Производные триазола и их применение при неврологических заболеваниях | |
| JP2019530667A (ja) | ピリジル置換のインドール化合物 | |
| HRP20160359T1 (hr) | Derivati kinazolindiona, njihovo dobivanje i njihove terapijske primjene | |
| JP2021506816A5 (https=) | ||
| CA2476012A1 (en) | Substituted pyridinones as modulators of p38 map kinase | |
| KR20200036005A (ko) | Tlr7/8/9의 억제제로서 유용한 치환된 인돌 화합물 | |
| JP2019519484A5 (https=) | ||
| JP2018534326A5 (https=) | ||
| JP2020529436A5 (https=) | ||
| RU2016141088A (ru) | 5-замещённые индазол-3-карбоксамиды и их получение и применение | |
| RU2006117326A (ru) | Амидные производные | |
| JP2009524589A5 (ja) | 置換されたイソキノリン−１，３（２ｈ，４ｈ）−ジオン、１−チオキソ−１，４−ジヒドロ−２ｈ−イソキノリン−３−オン、および１，４−ジヒドロ−３（２ｈ）−イソキノロン、ならびにキナーゼインヒビターとしてのそれらの使用 | |
| HRP20120457T1 (hr) | 4-(4-cijano-2-tioaril)dihidropirimidinoni i njihova uporaba | |
| JP2006512412A5 (ja) | 神経系の疾患の治療用のベンズアゼピン誘導体 | |
| JP2012515761A5 (https=) | ||
| KR20130038420A (ko) | 브루톤 티로신 키나아제의 억제제 | |
| JPWO2020231806A5 (https=) |